Skip to main content

Efficacy of fungicides with various modes of action in controlling the early stages of an Erysiphe necator‐induced epidemic

The full text article is not available for purchase.

The publisher only permits individual articles to be downloaded by subscribers.

BACKGROUND: Limiting the use of fungicides is due to become an important issue in managing Erysiphe necator (Schwein) Burrill infections in vineyards. The authors determined how three fungicides currently used by vine growers could be managed to control the early stages of an E. necator‐induced epidemic.

RESULTS: Leaf‐disc bioassays and field experiments suggested that the protectant quinoxyfen induced minor disruption in E. necator development, but compounds with protectant and curative properties (tebuconazole and trifloxystrobin) caused significant, although different, disruption during E. necator‐induced epidemics. Bioassays showed that each of the antifungals were most effective at different stages of fungal development, tebuconazole before sporulation and trifloxystrobin after sporulation of the colonies. Results from the bioassay also highlighted likely occurrences in the field, where several stages of fungal development are encountered simultaneously.

CONCLUSION: The present findings were complementary: leaf‐disc tests showed when the fungicides were most effective at inhibiting E. necator infection cycles; the field trial provided results in terms of incidence and severity of disease on bunches without reference to the pathogenic cycle development. A protection strategy combining the different types of fungicide under study is suggested. Copyright © 2010 Society of Chemical Industry
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: leaf‐disc bioassay; powdery mildew; quinoxyfen; tebuconazole; trifloxystrobin

Document Type: Research Article

Publication date: 2010-12-01

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more